Cargando…

Development and Implementation of a Pilot Registry for Monitoring the Efficacy and Safety of Novel Therapies in Patients with Systemic Lupus Erythematosus

The therapeutic armamentarium in Systemic Lupus Erythematosus (SLE) is expanding with the introduction of novel biologic and small-molecule agents. Complementary to randomized controlled trials, registry-based studies are advantageous due to the inclusion of a wider range of patients from daily prac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adamichou, Christina, Flouri, Irini, Fanouriakis, Antonios, Nikoloudaki, Myrto, Nikolopoulos, Dionysios, Repa, Argyro, Boki, Kyriaki, Chatzidionysiou, Katerina, Garyfallos, Alexandros, Boumpas, Dimitrios, Sidiropoulos, Prodromos, Bertsias, George
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Mediterranean Journal of Rheumatology (MJR) 2020
Materias:	Research Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7219637/ https://www.ncbi.nlm.nih.gov/pubmed/32411939 http://dx.doi.org/10.31138/mjr.31.1.87

Ejemplares similares

Lupus or not? SLE Risk Probability Index (SLERPI): a simple, clinician-friendly machine learning-based model to assist the diagnosis of systemic lupus erythematosus
por: Adamichou, Christina, et al.
Publicado: (2021)

Clinical response trajectories and drug persistence in systemic lupus erythematosus patients on belimumab treatment: A real-life, multicentre observational study
por: Nikoloudaki, Myrto, et al.
Publicado: (2023)

Comparative analysis of the sensitivity and specificity of the classification criteria and correlation with prognosis of disease in patients with Systemic Lupus Erythematosus
por: Adamichou, Christina, et al.
Publicado: (2018)

Persistence of Depression and Anxiety despite Short-Term Disease Activity Improvement in Patients with Systemic Lupus Erythematosus: A Single-Centre, Prospective Study
por: Nikoloudaki, Myrto, et al.
Publicado: (2022)

Correction: Nikoloudaki et al. Persistence of Depression and Anxiety despite Short-Term Disease Activity Improvement in Patients with Systemic Lupus Erythematosus: A Single-Centre, Prospective Study. J. Clin. Med. 2022, 11, 4316
por: Nikoloudaki, Myrto, et al.
Publicado: (2022)

Rheumatoid arthritis patients on persistent moderate disease activity on biologics have adverse 5-year outcome compared to persistent low-remission status and represent a heterogeneous group
por: Genitsaridi, Irini, et al.
Publicado: (2020)

Real-Life Outcome of Lupus Nephritis with Current Therapies: Study Protocol of a Multicentre Observational Study
por: Pappa, Maria, et al.
Publicado: (2022)

Rheumatoid arthritis patients initiating rituximab with low number of previous bDMARDs failures may effectively reduce rituximab dose and experience fewer serious adverse events than patients on full dose: a 5-year cohort study
por: Bertsias, Antonios, et al.
Publicado: (2022)

Progressive Multifocal Leukoencephalopathy in Systemic Lupus Erythematosus: A Consequence of Patient-Intrinsic or -Extrinsic Factors?
por: Emmanouilidou, Evgenia, et al.
Publicado: (2023)

High Comorbidity Burden in Patients with SLE: Data from the Community-Based Lupus Registry of Crete
por: Gergianaki, Irini, et al.
Publicado: (2021)

Cerebrovascular Events in Systemic Lupus Erythematosus: Diagnosis and Management
por: Nikolopoulos, Dionysis, et al.
Publicado: (2019)

Investigating the Role of T-bet(+) B Cells (ABCs/DN) in the Immunopathogenesis of Systemic Lupus Erythematosus
por: Sachinidis, Athanasios, et al.
Publicado: (2023)

Birth Registry of Women With Systematic Lupus Erythematosus: The Greek Experience
por: Ntali, Stella, et al.
Publicado: (2018)

Flares in systemic lupus erythematosus: diagnosis, risk factors and preventive strategies
por: Adamichou, Christina, et al.
Publicado: (2017)

Enhanced activity of NLRP3 inflammasome in peripheral blood cells of patients with active rheumatoid arthritis
por: Choulaki, Christianna, et al.
Publicado: (2015)

Changing paradigms in the treatment of systemic lupus erythematosus
por: Fanouriakis, Antonis, et al.
Publicado: (2019)

Cost of Illness, Quality of Life, and Work Productivity in Axial Spondyloarthritis Patients Receiving Biological Treatments in Greece
por: Kougkas, Nikolaos, et al.
Publicado: (2023)

Nailfold Videocapillaroscopy as a Candidate Biomarker for Organ Involvement and Prognosis in Patients with Systemic Sclerosis
por: Repa, Argyro, et al.
Publicado: (2019)

The value of the 2011 ASAS classification criteria in patients with Spondyloarthritis and the prognosis of non-radiographic axial Spondyloarthritis: data from a large cohort of a tertiary referral hospital
por: Kougkas, Nikolaos, et al.
Publicado: (2019)

Editorial: Lupus and the Brain: Advances in Neuropsychiatric Systemic Lupus Erythematosus
por: Fanouriakis, Antonis, et al.
Publicado: (2019)

Combined genetic and transcriptome analysis of patients with SLE: distinct, targetable signatures for susceptibility and severity
por: Panousis, Nikolaos I, et al.
Publicado: (2019)

Advances in Systemic Lupus Erythematosus (SLE): A case for optimism
por: Fanouriakis, Antonis, et al.
Publicado: (2017)

Transition to severe phenotype in systemic lupus erythematosus initially presenting with non-severe disease: implications for the management of early disease
por: Nikolopoulos, Dionysis S, et al.
Publicado: (2020)

Restoration of aberrant gene expression of monocytes in systemic lupus erythematosus via a combined transcriptome-reversal and network-based drug repurposing strategy
por: Nikolakis, Dimitrios, et al.
Publicado: (2023)

Demyelinating Syndromes in Systemic Lupus Erythematosus: Data From the “Attikon” Lupus Cohort
por: Nikolopoulos, Dionysis, et al.
Publicado: (2022)

Anxiety and depression severity in neuropsychiatric SLE are associated with perfusion and functional connectivity changes of the frontolimbic neural circuit: a resting-state f(unctional) MRI study
por: Antypa, Despina, et al.
Publicado: (2021)

Deciphering the Molecular Mechanism of Flares in Patients with Systemic Lupus Erythematosus through Single-Cell Transcriptome Analysis of the Peripheral Blood
por: Papanikolaou, Sofia, et al.
Publicado: (2022)

Management of lupus nephritis: a systematic literature review informing the 2019 update of the joint EULAR and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations
por: Kostopoulou, Myrto, et al.
Publicado: (2020)

Molecular Taxonomy of Systemic Lupus Erythematosus Through Data-Driven Patient Stratification: Molecular Endotypes and Cluster-Tailored Drugs
por: Garantziotis, Panagiotis, et al.
Publicado: (2022)

Altered hippocampal connectivity dynamics predicts memory performance in neuropsychiatric lupus: a resting-state fMRI study using cross-recurrence quantification analysis
por: Pentari, Anastasia, et al.
Publicado: (2023)

TLR-9, but not TLR-2, TLR-3 and TLR-4, is upregulated on peripheral blood mononuclear cells of patients with active systemic lupus erythematosus
por: Papadimitraki, ED, et al.
Publicado: (2005)

Systemic Lupus Erythematosus and COVID-19
por: Pappa, Maria, et al.
Publicado: (2023)

Systemic Lupus Erythematosus in Primary Care: An Update and Practical Messages for the General Practitioner
por: Gergianaki, Irini, et al.
Publicado: (2018)

Expression of programmed death (PD)-1 and PD-1 ligands (PD-L1, PD-L2) in peripheral blood mononuclear cells of patients with systemic lupus erythematosus
por: Bertsias, G, et al.
Publicado: (2005)

Pathogenic and Therapeutic Relevance of JAK/STAT Signaling in Systemic Lupus Erythematosus: Integration of Distinct Inflammatory Pathways and the Prospect of Their Inhibition with an Oral Agent
por: Alunno, Alessia, et al.
Publicado: (2019)

Episcleritis Related to Drug-Induced Lupus Erythematosus following Infliximab Therapy: A Case Report
por: Chatziralli, Irini P., et al.
Publicado: (2011)

Evolving phenotype of systemic lupus erythematosus in Caucasians: low incidence of lupus nephritis, high burden of neuropsychiatric disease and increased rates of late-onset lupus in the ‘Attikon’ cohort
por: Nikolopoulos, D, et al.
Publicado: (2020)

ATR-mediated DNA damage responses underlie aberrant B cell activity in systemic lupus erythematosus
por: Manolakou, Theodora, et al.
Publicado: (2022)

Transcriptome reprogramming and myeloid skewing in haematopoietic stem and progenitor cells in systemic lupus erythematosus
por: Grigoriou, Maria, et al.
Publicado: (2020)

Extensive fragmentation and re-organization of transcription in Systemic Lupus Erythematosus
por: Ntasis, Vasilis F., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_b3nc0af7dh26p5lp9n0hdchq8l